[HTML][HTML] Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
R Wang, S He, J Long, Y Wang, X Jiang… - … Hematology & Oncology, 2024 - Springer
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
R Wang, S He, J Long, Y Wang… - Experimental …, 2024 - pubmed.ncbi.nlm.nih.gov
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
[HTML][HTML] Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
R Wang, S He, J Long, Y Wang… - Experimental …, 2024 - ehoonline.biomedcentral.com
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
[HTML][HTML] Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
R Wang, S He, J Long, Y Wang, X Jiang… - Experimental …, 2024 - ncbi.nlm.nih.gov
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways.
R Wang, S He, J Long, Y Wang, X Jiang… - Experimental …, 2024 - europepmc.org
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways.
R Wang, S He, J Long, Y Wang, X Jiang… - Experimental …, 2024 - europepmc.org
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
[PDF][PDF] Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
R Wang, S He, J Long, Y Wang, X Jiang, M Chen… - 2024 - ehoonline.biomedcentral.com
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …
surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells …